Aspiriant LLC’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-741
Closed -$243K 284
2024
Q1
$243K Buy
741
+5
+0.7% +$1.47K 0.01% 285
2023
Q4
$202K Sell
736
-239
-25% -$56.7K 0.01% 300
2023
Q3
$298K Buy
975
+68
+7% +$23.5K 0.02% 225
2023
Q2
$321K Sell
907
-757
-45% -$241K 0.02% 212
2023
Q1
$556K Sell
1,664
-33
-2% -$9.74K 0.03% 167
2022
Q4
$358K Buy
1,697
+88
+5% +$17.6K 0.02% 200
2022
Q3
$335K Buy
1,609
+3
+0.2% +$772 0.02% 200
2022
Q2
$380K Hold
1,606
0.02% 190
2022
Q1
$700K Sell
1,606
-220
-12% -$107K 0.04% 151
2021
Q4
$1.2M Sell
1,826
-326
-15% -$210K 0.06% 120
2021
Q3
$1.43M Sell
2,152
-448
-17% -$304K 0.08% 95
2021
Q2
$1.59M Sell
2,600
-297
-10% -$176K 0.09% 86
2021
Q1
$1.57M Sell
2,897
-433
-13% -$239K 0.1% 77
2020
Q4
$1.78M Sell
3,330
-440
-12% -$198K 0.12% 72
2020
Q3
$1.23M Sell
3,770
-1,136
-23% -$347K 0.1% 86
2020
Q2
$1.35M Sell
4,906
-1,632
-25% -$368K 0.13% 68
2020
Q1
$1.14M Sell
6,538
-2,696
-29% -$646K 0.11% 73
2019
Q4
$2.58M Sell
9,234
-5,810
-39% -$1.45M 0.24% 51
2019
Q3
$2.72M Buy
15,044
+2,687
+22% +$559K 0.24% 63
2019
Q2
$3.38M Buy
12,357
+7,809
+172% +$2.36M 0.28% 52
2019
Q1
$1.29M Buy
4,548
+7
+0.2% +$1.67K 0.11% 93
2018
Q4
$951K Sell
4,541
-456
-9% -$115K 0.07% 106
2018
Q3
$1.96M Buy
4,997
+738
+17% +$272K 0.17% 81
2018
Q2
$1.46M Sell
4,259
-3,537
-45% -$1.06M 0.12% 91
2018
Q1
$1.96M Buy
+7,796
New +$2M 0.17% 77

Other funds holding ALGN

Aspiriant LLC's ALGN Position: Q2 2024 in Review

Aspiriant LLC sold out of Align Technology (ALGN) in Q2 2024, closing a stake of 741 shares — an estimated $243K sold.

Aspiriant LLC first reported a position in ALGN in Q1 2018 and held it in 25 quarters. The position peaked at $3.38M in Q2 2019. 767 funds tracked by Wall St. Rank hold ALGN as of Q2 2024.

  • Aspiriant LLC reported no remaining Align Technology position as of Q2 2024 after selling out during the quarter.
  • Aspiriant LLC sold 741 Align Technology shares in Q2 2024, an estimated $243K.
  • Aspiriant LLC first reported a position in Align Technology in Q1 2018 and held it in 25 quarters.
  • Aspiriant LLC's Align Technology position peaked at $3.38M in Q2 2019.
  • 767 funds tracked by Wall St. Rank held Align Technology as of Q2 2024.

Based on Aspiriant LLC's 13F filing for Q2 2024, filed 15 Jul 2024.